The bioavailability of cefpodoxime proxetil tablets relative to an oral solution.
The bioavailability of cefpodoxime proxetil tablets relative to an oral solution of cefpodoxime proxetil in a sucrose/alcohol/citric acid vehicle was studied in 11 healthy volunteers in a randomized, crossover study. Fasted subjects took one cefpodoxime proxetil 100 mg tablet or 50 mL of a 2 mg mL-1 cefpodoxime proxetil oral solution on two separate occasions. In a third study period, all subjects took a 100 mg dose of the oral solution with a high-fat meal to investigate the effect of food on cefpodoxime proxetil absorption from the oral solution. Serial blood samples were obtained over a 24 h period, and urine was collected for 48 h after dosing. Cefpodoxime concentrations in plasma and in urine were determined using HPLC methods. The bioavailability of cefpodoxime proxetil tablets relative to the oral solution was 82%, as determined from AUC ratios. There was no difference in the rate of cefpodoxime absorption between dosage forms. Food had no effect on the extent of drug absorption from the oral solution but did result in delayed absorption. These results suggest that complete dissolution of cefpodoxime proxetil is critical for optimal bioavailability.
Borin
M T
MT
Upjohn Company, Kalamazoo, MI 49001-0199, USA.
Forbes
K K
KK
Hughes
G S
GS
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001682:Biological Availability; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D002511:Cephalosporins / Q000493:pharmacokinetics; D018592:Cross-Over Studies; D005502:Food; D006801:Humans; D008297:Male; D013607:Tablets; D013997:Time Factors; D000097623:Cefpodoxime
D015296:Ceftizoxime; D002511:Cephalosporins; D013607:Tablets; D000097623:Cefpodoxime